The P-tau 217 Alzheimer's biomarker is surprisingly weak in preclinical studies

30-Jul-2026 - The misfolding of the amyloid-β protein is the strongest blood-based predictor of Alzheimer’s disease in the asymptomatic stage. It indicates the risk years before clinical diagnosis and significantly earlier than the widely used plasma biomarker P-tau 217. This is the conclusion of a study led ...

Advances in Cancer Research: New Software Simplifies the Analysis of Complex Tissue Images

28-Jul-2026 - Thanks to modern imaging techniques, it is now possible to determine, using just a single tissue sample, which cells are present in the tissue and how they are organized. This breakthrough has significantly simplified the diagnosis and research of various diseases. An interdisciplinary research ...

Skin Cancer on the Face: Ultrasound Shows How Deep the Tumor Grows

24-Jul-2026 - Summer, sun, UV radiation: The warm season puts particular strain on the skin—especially on the face. The nose, ears, forehead, and scalp are often exposed to the sun without protection for years on end. It is precisely in these areas that skin cancers such as basal cell carcinoma and squamous ...

AI detects cancer cells and evaluates the accuracy of its diagnosis

Researchers Are Developing a Transparent AI System for Diagnosing Lymphomas

17-Jul-2026 - Diagnosing certain types of blood and lymph node cancers could become easier and more transparent in the future. Researchers at the University of Marburg have developed “FlowXAI,” a new AI system that assists doctors in classifying B-cell lymphomas. Unlike many existing methods, the application ...

Dog Noses and AI Provide New Clues About Long COVID

What dogs can sniff out, mass spectrometry can reveal

06-Jul-2026 - Researchers at the Technical University of Braunschweig, Hannover Medical School, and the University of Veterinary Medicine Hannover were able to demonstrate that post-COVID syndrome can be identified based on olfactory signatures. The results also show a correlation between the assessments of ...

Hospital "Fingerprint" Helps AI Identify Misdiagnoses in Cancer Tissue

The origin of a sample must not influence the result: Evaluation criteria for trustworthy clinical AI

29-Jun-2026 - A new study by BIFOLD researchers at TU Berlin, in collaboration with the Berlin-based AI company Aignostics, Ludwig Maximilian University (LMU) in Munich, and the Netherlands Cancer Institute (NKI), shows that today’s AI models for pathology can often be influenced simply by the hospital from ...

2026 Future Insight Prize Goes to Spear’s Vasilis Ntziachristos

The € 300,000 research grant award recognizes Ntziachristos’ pioneering work in enabling non-invasive and continuous monitoring of human biology

25-Jun-2026 - Merck awarded the 2026 Future Insight Prize to Prof. Dr. Vasilis Ntziachristos, representing optoacoustic and fluorescence solutions company Spear, Munich, Germany, a spin-off of Helmholtz Munich and Technical University of Munich. Ntziachristos is also the Chair of Biological Imaging at the ...

Lab-on-a-Chip platform shows how immune cells attack cancer cells

CellTrap runs on a standard laboratory microscopes and visualizes individual cell contacts

22-Jun-2026 - Immunotherapies are a promising approach in the fight against cancer. Researchers at the Technical University of Munich (TUM) have developed a lab-on-a-chip system called CellTrap. It makes it possible to observe the interactions between immune cells and cancer cells at the single-cell level. The ...

AI Diagnoses Brain Tumors in Minutes Instead of Weeks

AI system outperforms experienced specialists

12-Jun-2026 - Experts in Heidelberg have developed an AI system that can classify brain tumors with unprecedented accuracy using standard microscopic tissue sections. Using digitized standard stains, the system identifies more than 100 molecular subtypes of central nervous system tumors, delivers results ...

Generative Artificial Intelligence Can Significantly Reduce the Number of Animal Experiments

Between 30 and 50 percent fewer mice for pharmacological research experiments

15-May-2026 - Researchers at Goethe University and Philipps University Marburg, in collaboration with the Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, have developed a new artificial intelligence to reduce animal experiments. The AI, called genESOM, was trained to “learn” the ...